Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Oct 20;128(16):2096-2097.
doi: 10.1182/blood-2016-07-728766. Epub 2016 Aug 17.

Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes

Peter L Greenberg  1 , Heinz Tuechler  2 , Julie Schanz  3 , Guillermo Sanz  4 , Guillermo Garcia-Manero  5 , Francesc Solé  6 , John M Bennett  7 , David Bowen  8 , Pierre Fenaux  9 , Francois Dreyfus  10 , Hagop Kantarjian  5 , Andrea Kuendgen  11 , Alessandro Levis  12 , Luca Malcovati  13 , Mario Cazzola  13 , Jaroslav Cermak  14 , Christa Fonatsch  15 , Michelle M Le Beau  16 , Marilyn L Slovak  17 , Otto Krieger  18 , Michael Luebbert  19 , Jaroslaw Maciejewski  20 , Silvia M M Magalhaes  21 , Yasushi Miyazaki  22 , Michael Pfeilstöcker  2 , Mikkael Sekeres  20 , Wolfgang R Sperr  15 , Reinhard Stauder  23 , Sudhir Tauro  24 , Peter Valent  15 , Teresa Vallespi  25 , Arjan A van de Loosdrecht  26 , Ulrich Germing  11 , Detlef Haase  3
Affiliations
Comment

Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes

Peter L Greenberg et al. Blood. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405. - PubMed
    1. Brunning RD, Orazi A, Germing U, et al. Myelodysplastic syndromes/neoplasms. In: Swerdlow S, Campo E, Harris NL, et al., editors. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon: IARC Press; 2008. p. 88.
    1. Wimazal F, Fonatsch C, Thalhammer R, et al. Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: the diagnostic interface. Leuk Res. 2007;31(11):1461–1468. - PubMed
    1. Kwok B, Hall JM, Witte JS, et al. MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance. Blood. 2015;126(21):2355–2361. - PMC - PubMed
    1. Valent P, Bain BJ, Bennett JM, et al. Idiopathic cytopenia of undetermined significance (ICUS) and idiopathic dysplasia of uncertain significance (IDUS), and their distinction from low risk MDS. Leuk Res. 2012;36(1):1–5. - PubMed